كتاب
Localized rectal Cancer
- References
1. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1453.
2. https://www.esmo.org/guidelines/guidelines-by-topic/esmo-clinical-practice-guideline
3. https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-guidelines
4. https://gco.iarc.who.int/media/globocan/factsheets/populations/818-egypt-fact-sheet.pdf
5. Jacobs L, Meek DB, van Heukelom J, Bollen TL, Siersema PD, Smits AB, Tromp E, Los M, Weusten
BL, van Lelyveld N.: Comparison of MRI and colonoscopy in determining tumor height in rectal
cancer.United European Gastroenterol J. 2018 Feb;6(1):131-137.
6. Lahaye MJ, Engelen SM, Nelemans PJ, et al. Imaging for predicting the risk factors–the
circumferential resection margin and nodal dis- ease–of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR. 2005;26(4):259-268.
7. Di Fabio F, Allievi N, Lord A, et al. MRI-predicted extramural vascular invasion and tumour deposit are main predictors of disease-free survival in patients undergoing surgical resection for rectal cancer. BJS Open. 2024;8(1):zrad139.
8. Conroy T, Bosset JF, Etienne PL, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(5):702-715.
9. Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guide- lines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386-1422.
10. Bujko k., Richter p., Smith F.M. et al., Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders: A prospective multicentre study January 2013, Radiotherapy and Oncology 106(2).
11. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemo- radiation for rectal cancer. Br J Surg. 2006;93(10):1215-1223.
12. Ngan SY, Burmeister B, Fisher RJ, et al. Randomized trial of short- course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans- Tasman Radiation Oncology Group trial 01.04. J Clin Oncol. 2012;30(31):3827-3833.
13. Lutz MP, Zalcberg JR, Glynne-Jones R, et al. Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer. Eur J Cancer. 2016;63:11-24.
14. Dijkstra EA, Nilsson PJ, Hospers GAP, et al. Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared with long-course chemoradiotherapy and surgery:a 5-year follow-up of the RAPIDO trial, Ann Surg. 2023;278(4).
15. Zhang J, Chi P, Shi L, et al. Neoadjuvant modified infusional fluoro- uracil, leucovorin, and oxaliplatin with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: updated results of the FOWARC study after a median follow-up of 10 years. J Clin Oncol. 2025;43(6):633-640.
16. Glimelius B, Khan T, Adolfsson K, et al. Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US). EClinicalMedicine. 2024;75:102771.
17. Conroy T, Castan F, Etienne PL, et al. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial. Ann Oncol. 2024;35(10):873- 881.
18. Boublikova L., Novakova A., Simsa J.,Lohynska R., Total neoadjuvant therapy in rectal cancer: the evidence and expectations, Crit Rev Oncol Hematol. 2023 Dec:192:104196.
19. van der Valk MJM, Marijnen CAM, van Etten B, et al. Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer e results of the international randomized RAPIDO-trial. Radiother Oncol. 2020;147:75-83.
20. Verheij FS, Omer DM, Williams H, et al. Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial. J Clin Oncol. 2024;42(5):500-506.
21. Schrag D, Shi Q, Weiser MR, et al. Preoperative treatment of locally advanced rectal cancer. N Engl J Med. 2023;389(4):322-334.
22. Ding PR, Wang XZ, Li YF, et al. LBA26 Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): final results of a phase III trial. Ann Oncol. 2023;34(suppl 2):S1267-S1268.
23. Zhang J, Chi P, Shi L, et al. Neoadjuvant modified infusional fluoro- uracil, leucovorin, and oxaliplatin with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: updated results of the FOWARC study after a median follow-up of 10 years. J Clin Oncol. 2025;43(6):633-640
24. Zi-Tong Zhang, Wei-Wei Xiao, Li-Ren Li , et al., Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for initially unresectable locally advanced colon cancer: short-term outcomes of an open-label, single-centre, randomised, controlled, phase 3 trial, eClinicalMedicine, . 2024 Sep 21;76:102836. doi: 10.1016/j.eclinm.2024.102836
25. Mari Miyata, Takayuki Ohguri, Katsuya Yahara, Shinsaku Yamaguchi, Hajime Imada, Yukunori Korogi, Salvage radiotherapy for second oligo-recurrence in patients with breast cancer, J Radiat Res
2017 Nov 22;59(1):58–66. doi: 10.1093/jrr/rrx066
26. Lambregts DMJ, Bogveradze N, Blomqvist LK, et al. Current contro- versies in TNM for the radiological staging of rectal cancer and how to deal with them: results of a global online survey and multidisciplinary expert consensus. Eur Radiol. 2022;32(7):4991-5003.
27. Shihab OC, How P, West N, et al. Can a novel MRI staging system for low rectal cancer aid surgical planning? Dis Colon Rectum. 2011;54(10): 1260-1264.
28. Custers PA, Geubels BM, Beets GL, et al. Defining near-complete response following (chemo)radiotherapy for rectal cancer: systematic review. Br J Surg. 2022;110(1):43-49.
29. panelKerKan Tan, Charles B. Tsang, Staging of Rectal Cancer—Technique and Interpretation of Evaluating Rectal Adenocarcinoma, uT1-4, N Disease: 2D and 3D Evaluation, Seminars in Colon and Rectal Surgery Volume 21, Issue 4, December 2010, Pages 197-204.
30. Volkan Özben, Nuri Okkabaz, Turkish Colorectal Cancer Database Study Group, Partial Versus Total Mesorectal Excision for the Surgical Treatment of Mid-Rectal Cancer: An Assessment from the Turkish Society of Colon and Rectal Surgery’s Colorectal Cancer Database, Turk J Colorectal Dis 2024;34:41-49
31. Pimentel-Nunes P, Libânio D, Bastiaansen BAJ, et al. Endoscopic submucosal dissection for superficial gastrointestinal lesions: Euro- pean Society of Gastrointestinal Endoscopy (ESGE) Guideline - update 2022. Endoscopy. 2022;54(6):591-622.
32. Burton S, Brown G, Daniels IR, et al. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer. 2006;94(3):351-357.
33. Rutkowski A, Bujko K, Nowacki MP, et al. Distal bowel surgical margin shorter than 1 cm after preoperative radiation for rectal cancer: is it safe? Ann Surg Oncol. 2008;15(11):3124-3131. 81.
34. Fitzgerald TL, Brinkley J, Zervos EE. Pushing the envelope beyond a centimeter in rectal cancer: oncologic implications of close, but negative margins. J Am Coll Surg. 2011;213(5):589-595.
35. Chen Z, Sasaki K, Murono K, et al. Oncologic status of obturator lymph node metastases in locally advanced low rectal cancer: a Japanese multi-institutional study of 3487 patients. Ann Surg Oncol. 2022;29:4210-4219.
36. Quirke P, Steele R, Monson J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373(9666):821-828.
38. Elisa Cassinotti, Giorgio Palazzini, Massimiliano Della Porta, Ilaria Grosso, Luigi Bon, Transanal total mesorectal excision (TaTME): tips and tricks of a new surgical technique.,Ann Laparosc Endosc Surg 2017;2:1-8.
39. Dajana Cuicchi, Giovanni Castagna, Stefano Cardelli, Cristina Larotonda, Benedetta Petrello, Gilberto Poggioli,Restaging rectal cancer following neoadjuvant chemoradiotherapy,
World J Gastrointest Oncol. 2023 May 15;15(5):700–712. doi: 10.4251/wjgo.v15.i5.700
40. J. Wyatt y, S.G. Powell y, S. Ahmed et al., Watch and Wait in Rectal Cancer After a Complete Response to Chemoradiotherapy Is It Safe and Are We Doing Enough?,Clinical Oncology 35 (2023) 117e123.
41. Shiru L Liu, Winson Y Cheung, Role of surveillance imaging and endoscopy in colorectal cancer follow-up: Quality over quantity?, World J Gastroenterol 2019 January 7; 25(1): 59-68.
42. 7. Petersen SH, Harling H, Kirkeby LT, et al. Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst Rev. 2012;2012(3):Cd004078. 98.
43. Bosset JF, Calais G, Mineur L, et al. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol. 2014;15(2):184-190.
44. Jin‑hu Chen, Qing Ye and Feng Huang, Determining the survival benefit of postoperative radiotherapy in patients with pT1-3N1M0 rectal cancer undergoing total mesorectal excision: a retrospective analysis,BMC Gastroenterology (2023) 23:83.
45. Margaret Lee, Peter Gibbs, Rachel Wong, Multidisciplinary Management of Locally Advanced Rectal Cancer—An Evolving Landscape?, Clinical Colorectal Cancer14,4, 2015: 251-261.
